Jumonji domain containing 5 is a potential prognostic indicator in non-small cell lung cancer patients who received platinum-based chemotherapy

BACKGROUND: Platinum-based chemotherapy is the cornerstone of non-small cell lung cancer (NSCLC) therapy. However, the molecular mechanisms and predictive markers of platinum chemoresistance have not been fully understood. Our recent study revealed that Jumonji domain containing 5 (JMJD5) expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Xueping, Ma, Xiaojing, Fang, Mao, Zhong, Like, Liu, Hui, Liu, Hong, Tong, Yinghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798029/
https://www.ncbi.nlm.nih.gov/pubmed/35117010
http://dx.doi.org/10.21037/tcr.2019.10.16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798029/
https://www.ncbi.nlm.nih.gov/pubmed/35117010
http://dx.doi.org/10.21037/tcr.2019.10.16

Ejemplares similares